Skip to main content

Table 1 Patient characteristics

From: Atrial natriuretic peptide infusion and nitric oxide inhalation in patients with acute respiratory distress syndrome

       

Lung

 

PVRI

   

Patient

  

Age

PaO2/FiO2

 

Compliance

Injury

MPAP

(dyne s/

Inotropic support

  

number

Diagnosis

Sex

(years)

(kPa)

Qs/Qt (%)

(ml/cmH2O)

Score

(mmHg)

cm5/m2)

(μg/kg/min)

Organ failure

Survival

1

Reaction to chemotherapy

M

30

16.1

45

28

3.25

20

167

 

K

NS

2

Multiple blood transfusion

F

56

15

41

28

3

35

493

Dobutamine 15,

 

S

          

Dopamine 8

  

3

Submersion

M

52

23.5

22

45

2.75

22

337

Dobutamine 10

 

S

4

Pneumonia/sepsis

F

65

13.7

25

24

2.75

28

504

Dobutamine 10

K

S

5

Pneumonia

M

40

17.2

33

40

2.75

19

181

  

S

6

Aspiration

F

66

24

32

26

2.5

20

225

Dobutamine 5

K

NS

7

Sepsis

F

40

20.1

32

34

2.75

36

327

Dobutamine 20,

 

NS

          

Norepinephrine 0.3

  

8

Trauma/aspiration

M

48

15.8

35

42

2.5

25

382

Norepinephrine 0.7

L

S

9

Aspiration

M

55

17.7

34

20

2.75

27

301

Dobutamine 5,

 

S

          

Norepinephrine 0.08

  

10

Pneumonia

F

50

16

34

59

2.75

19

224

Dobutamine 5

 

S

  1. MPAP, Mean pulmonary artery pressure; PVRI, pulmonary vascular resistance index; M, male; F, female; K, kidney (serum creatinine >177 μmol/l); L, liver (serum bilirubin >40 μmol/l); NS, nonsurvivor (hospital mortality); S, survivor.
Back to article page

Critical Care

ISSN: 1364-8535